Intervention to enhance adherence to mandibular advancement appliance in patients with obstructive sleep apnoea: study protocol for a randomised clinical trial

Harishri Tallamraju, J Tim Newton, Padhraig S Fleming, Ama Johal, Harishri Tallamraju, J Tim Newton, Padhraig S Fleming, Ama Johal

Abstract

Background: Obstructive sleep apnoea (OSA) is a sleep-related breathing disorder characterised by the repeated episodic collapse of the upper airway during sleep, resulting in sleep deprivation, giving rise to apnoeas and hypopnoeas. Based on the severity of OSA, there are two primary treatment modalities, continuous positive airway pressure (CPAP) and mandibular advancement appliances (MAA); both are adherence-dependent. MAA is offered to those with mild to moderate OSA and is prescribed as an alternative to patients intolerable to CPAP. However, adherence to MAA treatment is variable and declines over time. Hence, the current study aims to assess the effectiveness of the stage-matched intervention, the Health Action Process Approach (HAPA), on adherence to MAA in patients with OSA.

Methods: A single-centre randomised clinical trial will be undertaken at Bart's Health NHS Trust. Fifty-six participants with newly diagnosed OSA are planned to be enrolled in the study and randomised to intervention care (IC) and standardised care (SC) groups. Participants in the SC group will receive routine care whilst participants in the IC group will receive the stage-matched intervention, developed using the HAPA model. Data indicating MAA adherence will be collected both objectively and subjectively, from micro-sensors embedded in the MAA design and sleep diaries, respectively at 3, 6, 18 and 36 months. In addition, a range of questionnaires designed to assess risk perception, outcome expectancy, and self-efficacy (SEMSA) and quality of sleep (PSQI and ESS) and life (EQ-5DL), socio-economic and social support scales will be used.

Discussion: The currently available treatments for obstructive sleep apnoea depend entirely on the patient's acceptance and use. There are several factors that affect cooperation and wear for example patients' awareness of their condition, social support and psychological behaviour. In addition, mood, such as anxiety, stress, and depression, may affect wear. At the same time, we know that interventions involving more education and behaviour approaches can help patients adapt more easily to some treatments. As a result, the present trial aims to explore the potential role of these factors to maximise treatment success and minimise side effects.

Trial registration: ClinicalTrials.gov NCT04092660 . Registered on September 6, 2019.

Keywords: Health Action Process Approach; Mandibular advancement appliance; Obstructive sleep apnoea; Patient adherence; Staged-matched intervention.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Study Flow diagram

References

    1. Banno K, Kryger MH. Sleep apnea: clinical investigations in humans. Sleep Med. 2007;8(4):400–426. doi: 10.1016/j.sleep.2007.03.003.
    1. McMillan A, Bratton DJ, Faria R, Laskawiec-Szkonter M, Griffin S, Davies RJ, et al. A multicentre randomised controlled trial and economic evaluation of continuous positive airway pressure for the treatment of obstructive sleep apnoea syndrome in older people: PREDICT. Health Technol Assessment (Winchester, England) 2015;19(40):1–188. doi: 10.3310/hta19400.
    1. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006–1014. doi: 10.1093/aje/kws342.
    1. Deng T, Wang Y, Sun M, Chen B. Stage-matched intervention for adherence to CPAP in patients with obstructive sleep apnea: a randomized controlled trial. Schlaf Atmung [Sleep & breathing] 2013;17(2):791–801. doi: 10.1007/s11325-012-0766-3.
    1. American Academy of Sleep Medicine. International classification of sleep disorders. Diagnostic Coding Manual. 2005:51–5.
    1. Network SIG . Management of obstructive sleep apnoea/hypopnoea syndrome in adults: a national clinical guideline: Scottish Intercollegiate Guidelines Network. 2003.
    1. McDaid C, Griffin S, Weatherly H, Duree K, Van der Burgt M, Van Hout S, et al. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health Technol Assessment (Winchester, England). 2009;13(4):iii-iv, xi.
    1. Ramar K, Dort LC, Katz SG, Lettieri CJ, Harrod CG, Thomas SM, Chervin RD. Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015. J Clin Sleep Med. 2015;11(7):773–827. doi: 10.5664/jcsm.4858.
    1. Lim J, Lasserson TJ, Fleetham J, Wright JJ. Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev. 2006(1).
    1. Sharples LD, Clutterbuck-James AL, Glover MJ, Bennett MS, Chadwick R, Pittman MA, Quinnell TG. Meta-analysis of randomised controlled trials of oral mandibular advancement devices and continuous positive airway pressure for obstructive sleep apnoea-hypopnoea. Sleep Med Rev. 2016;27:108–124. doi: 10.1016/j.smrv.2015.05.003.
    1. Schwartz M, Acosta L, Hung Y-L, Padilla M, Enciso R. Effects of CPAP and mandibular advancement device treatment in obstructive sleep apnea patients: a systematic review and meta-analysis. Sleep Breath. 2018;22(3):555–568. doi: 10.1007/s11325-017-1590-6.
    1. Saglam-Aydinatay B, Taner T. Oral appliance therapy in obstructive sleep apnea: Long-term adherence and patients’ experiences. Medicina Oral Patologia Oral Y Cirugia Bucal. 2018;23(1):E72–EE7.
    1. Hoffstein V. Review of oral appliances for treatment of sleep-disordered breathing. Sleep Breath 2007;11(1):1-22, 1, DOI: 10.1007/s11325-006-0084-8.
    1. Dieltjens M, Vanderveken OM, Van den Bosch D, Wouters K, Denollet J, Verbraecken JA, et al. Impact of type D personality on adherence to oral appliance therapy for sleep-disordered breathing. Sleep Breath. 2013;17(3):985–991. doi: 10.1007/s11325-012-0788-x.
    1. Walker-Engström M-L, Tegelberg Å, Wilhelmsson B, Ringqvist I. 4-year follow-up of treatment with dental appliance or uvulopalatopharyngoplasty in patients with obstructive sleep apnea: a randomized study. Chest. 2002;121(3):739–746. doi: 10.1378/chest.121.3.739.
    1. de Almeida FR, Lowe AA, Tsuiki S, Otsuka R, Wong M, Fastlicht S, Ryan F. Long-Term Compliance and Side Effects of Oral Appliances Used for the Treatment of Snoring and Obstructive Sleep Apnea Syndrome. J Clin Sleep Med. 2005;1(2):143–152. doi: 10.5664/jcsm.8978.
    1. Haviv Y, Zini A, Almoznino G, Keshet N, Sharav Y, Aframian D. Assessment of interfering factors in non-adherence to oral appliance therapy in severe sleep apnea. Oral Dis. 2017;23(5):629–635. doi: 10.1111/odi.12633.
    1. Johal A, Agha B. Ready-made versus custom-made mandibular advancement appliances in obstructive sleep apnea: A systematic review and meta-analysis. J Sleep Res. 2018;27(6):e12660. doi: 10.1111/jsr.12660.
    1. Pantin CC, Hillman DR, Tennant M. Dental side effects of an oral device to treat snoring and obstructive sleep apnea. Sleep. 1999;22(2):237–240. doi: 10.1093/sleep/22.2.237.
    1. Clark GT, Sohn J-W, Hong CN. Treating obstructive sleep apnea and snoring: assessment of: an anterior mandibular positioning device. J Am Dent Assoc. 2000;131(6):765–771. doi: 10.14219/jada.archive.2000.0275.
    1. Fritsch KM, Iseli A, Russi EW, Bloch KE. Side effects of mandibular advancement devices for sleep apnea treatment. Am J Respir Crit Care Med. 2001;164(5):813–818. doi: 10.1164/ajrccm.164.5.2003078.
    1. McGown A, Makker H, Battagel J, L'Estrange P, Grant H, Spiro S. Long-term use of mandibular advancement splints for snoring and obstructive sleep apnoea: a questionnaire survey. Eur Respir J. 2001;17(3):462–466. doi: 10.1183/09031936.01.17304620.
    1. Bondemark L. Does 2 years’ nocturnal treatment with a mandibular advancement splint in adult patients with snoring and OSAS cause a change in the posture of the mandible? Am J Orthod Dentofac Orthop. 1999;116(6):621–628. doi: 10.1016/S0889-5406(99)70196-4.
    1. Fransson AM, Tegelberg Å, Svenson BA, Wenneberg B, Isacsson G. Validation of measurements of mandibular protrusion in the treatment of obstructive sleep apnoea and snoring with a mandibular protruding device. Eur J Orthodontics. 2003;25(4):377–383. doi: 10.1093/ejo/25.4.377.
    1. Ringqvist M, Walker-Engström M-L, Tegelberg Å, Ringqvist I. Dental and skeletal changes after 4 years of obstructive sleep apnea treatment with a mandibular advancement device: a prospective, randomized study. Am J Orthod Dentofac Orthop. 2003;124(1):53–60. doi: 10.1016/S0889-5406(03)00240-3.
    1. Robertson C, Herbison P, Harkness M. Dental and occlusal changes during mandibular advancement splint therapy in sleep disordered patients. Eur J Orthodontics. 2003;25(4):371–376. doi: 10.1093/ejo/25.4.371.
    1. Marklund M, Stenlund H, Franklin KA. Mandibular advancement devices in 630 men and women with obstructive sleep apnea and snoring: tolerability and predictors of treatment success. Chest. 2004;125(4):1270–1278. doi: 10.1378/chest.125.4.1270.
    1. Broström A, Strömberg A, Mårtensson J, Ulander M, Harder L, Svanborg E. Association of Type D personality to perceived side effects and adherence in CPAP-treated patients with OSAS. J Sleep Res. 2007;16(4):439–447. doi: 10.1111/j.1365-2869.2007.00620.x.
    1. Schwarzer R, Luszczynska A. How to overcome health-compromising behaviors: The health action process approach. Eur Psychol. 2008;13(2):141–151. doi: 10.1027/1016-9040.13.2.141.
    1. Carballo NJ, Alessi CA, Martin JL, Mitchell MN, Hays RD, Col N, et al. Perceived Effectiveness, Self-efficacy, and Social Support for Oral Appliance Therapy Among Older Veterans With Obstructive Sleep Apnea. Clin Ther. 2016;37(11):2407–2415. doi: 10.1016/j.clinthera.2016.09.008.
    1. Stepnowsky CJ, Jr, Dimsdale JE. Dose–response relationship between CPAP compliance and measures of sleep apnea severity. Sleep Med. 2002;3(4):329–334. doi: 10.1016/S1389-9457(02)00010-2.
    1. De Zeeuw J, Baberg H, Duchna H, Kempkens D, Walther J, Schultze-Werninghaus G, et al. Locus of control belief is a predictor of CPAP-compliance in patients with obstructive sleep apnea syndrome. Pneumologie (Stuttgart, Germany) 2007;61(5):283–290. doi: 10.1055/s-2007-959162.
    1. Olsen S, Smith S, Oei TP, Douglas J. Cues to starting CPAP in obstructive sleep apnea: development and validation of the cues to CPAP use questionnaire. J Clin Sleep Med. 2010;6(3):229–237. doi: 10.5664/jcsm.27819.
    1. Chervin RD, Theut S, Bassetti C, Aldrich MS. Compliance with nasal CPAP can be improved by simple interventions. Sleep. 1997;20(4):284–289. doi: 10.1093/sleep/20.4.284.
    1. Hui DS, Chan JK, Choy DK, Ko FW, Li TS, Leung RC, et al. Effects of augmented continuous positive airway pressure education and support on compliance and outcome in a Chinese population. Chest. 2000;117(5):1410–1416. doi: 10.1378/chest.117.5.1410.
    1. Bakker JP, Wang R, Weng J, Aloia MS, Toth C, Morrical MG, Gleason KJ, Rueschman M, Dorsey C, Patel SR, Ware JH, Mittleman MA, Redline S. Motivational Enhancement for Increasing Adherence to CPAP: A Randomized Controlled Trial. Chest. 2016;150(2):337–345. doi: 10.1016/j.chest.2016.03.019.
    1. Wozniak DR, Lasserson TJ, Smith I. Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. Cochrane Database Syst Rev. 2014(1).
    1. Sawyer AM, Gooneratne NS, Marcus CL, Ofer D, Richards KC, Weaver TE. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev. 2011;15(6):343–356. doi: 10.1016/j.smrv.2011.01.003.
    1. Dzierzewski JM, Wallace DM, Wohlgemuth WK. Adherence to continuous positive airway pressure in existing users: self-efficacy enhances the association between continuous positive airway pressure and adherence. J Clin Sleep Med. 2016;12(2):169–176. doi: 10.5664/jcsm.5478.
    1. Wiedemann AU, Lippke S, Reuter T, Schüz B, Ziegelmann JP, Schwarzer R. Prediction of stage transitions in fruit and vegetable intake. Health Educ Res. 2009;24(4):596–607. doi: 10.1093/her/cyn061.
    1. Lippke S, Schwarzer R, Ziegelmann JP, Scholz U, Schüz B. Testing stage-specific effects of a stage-matched intervention: a randomized controlled trial targeting physical exercise and its predictors. Health Educ Behav. 2010;37(4):533–546. doi: 10.1177/1090198109359386.
    1. Schüz B, Sniehotta FF, Mallach N, Wiedemann AU, Schwarzer R. Predicting transitions from preintentional, intentional and actional stages of change. Health Educ Res. 2009;24(1):64–75. doi: 10.1093/her/cym092.
    1. Noar SM, Benac CN, Harris MS. Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions. Psychol Bull. 2007;133(4):673–693. doi: 10.1037/0033-2909.133.4.673.
    1. Weinstein ND, Rothman AJ, Sutton SR. Stage theories of health behavior: conceptual and methodological issues. Health Psychol. 1998;17(3):290–299. doi: 10.1037/0278-6133.17.3.290.
    1. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. Am Psychol. 1992;47(9):1102–1114. doi: 10.1037/0003-066X.47.9.1102.
    1. Presseau J, Schwalm J, Grimshaw JM, Witteman HO, Natarajan MK, Linklater S, et al. Identifying determinants of medication adherence following myocardial infarction using the Theoretical Domains Framework and the Health Action Process Approach. Psychol Health. 2017;32(10):1176–1194. doi: 10.1080/08870446.2016.1260724.
    1. Pakpour AH, Gellert P, Asefzadeh S, Updegraff JA, Molloy GJ, Sniehotta FF. Intention and planning predicting medication adherence following coronary artery bypass graft surgery. J Psychosom Res. 2014;77(4):287–295. doi: 10.1016/j.jpsychores.2014.07.001.
    1. Wilson H, Sheehan M, Palk G, Watson A. Self-efficacy, planning, and drink driving: Applying the health action process approach. Health Psychol. 2016;35(7):695–703. doi: 10.1037/hea0000358.
    1. Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107–115. doi: 10.1111/j.1365-2648.2007.04569.x.
    1. QMUL. Sleep apnoea and Treatment Available 2019.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다